| Patent application number | Description | Published |
|---|
| 20100252047 | REMOTE FLUORINATION OF FIBROUS FILTER WEBS - A method of making a fluorinated fibrous web, which method includes providing a nonwoven web | 10-07-2010 |
| 20110162653 | REMOTE FLUORINATION OF FIBROUS FILTER WEBS - A method of making a fluorinated fibrous web, which method includes providing a nonwoven web | 07-07-2011 |
| 20120121238 | APPARATUS AND METHODS FOR DELIVERING A HEATED FLUID - Herein are disclosed apparatus and methods for delivering a heated fluid. The apparatus comprises at least a preheat zone, an expansion zone, and an expanded zone comprising a plurality of trim heaters, at least one fluid flow-distribution sheet, and an outlet. | 05-17-2012 |
| 20120256357 | USE OF COANDA EFFECT DEVICES TO PRODUCE MELTBLOWN WEBS WITH IMPROVED SIDE-TO-SIDE UNIFORMITY - An apparatus for producing meltblown webs includes a meltblowing die having a plurality of filament outlets, a collector for receiving filaments of polymeric material expelled from the filament outlets, and a first Coanda effect device positioned adjacent to the path of the filaments adjacent to the last filament outlet at an end of the meltblowing die. Methods of forming meltblown webs using such an apparatus are also disclosed. | 10-11-2012 |
| 20150024148 | REMOTE FLUORINATION OF FIBROUS FILTER WEBS - A method of making a fluorinated fibrous web, which method includes providing a nonwoven web | 01-22-2015 |
| Patent application number | Description | Published |
|---|
| 20130213454 | COATINGS FOR OPTICAL COMPONENTS OF SOLAR ENERGY SYSTEMS - The present application is directed to a method of providing a coating to a surface of an optical element of a solar energy conversion system. The method comprises contacting the surface of the optical element with an aqueous coating composition comprising water and silica nanoparticles dispersed in the water, and drying the coating composition to form a nanoparticle coating. The coating composition has a pH of the composition of 5 or higher. The coating composition comprises an aqueous continuous liquid phase; silica nanoparticles having a volume average particle diameter of 150 nanometers or less dispersed in the aqueous continuous liquid phase; and an organic polymer binder. | 08-22-2013 |
| 20130220402 | COATINGS FOR OPTICAL COMPONENTS OF SOLAR ENERGY SYSTEMS - The present application is directed to a method of providing a coating to a surface of an optical element of a solar energy conversion system. The method comprises coating the surface of the optical element with an aqueous coating composition comprising water and silica nanoparticles dispersed in the water; and drying the coating composition to form a nanoparticle coating. The silica nanoparticles comprise a polymer core surrounded by a shell comprising nonporous silica particles disposed on the polymer core. | 08-29-2013 |
| 20130319493 | COATINGS FOR OPTICAL COMPONENTS OF SOLAR ENERGY SYSTEMS - The present application is directed to a method of providing a coating to a surface of an optical element of a solar energy conversion system. The method comprises contacting the surface of the optical element with an aqueous coating composition comprising water and silica nanoparticles dispersed in the water and drying the coating composition to form a nanoparticle coating. The coating composition comprises an aqueous dispersion with a pH of less than 5 and an acid having a pKa of <3.5. | 12-05-2013 |
| 20140083481 | PHOTOVOLTAIC MODULE - A photovoltaic module including a backsheet and a plurality of photovoltaic cells overlying the backsheet is disclosed. The backsheet has open areas not covered by the photovoltaic cells. The backsheet may be a reflective backsheet that includes a multilayer optical film, or the photovoltaic module may include a reflective multilayer optical film separate from the backsheet. The multilayer optical film has an optical stack with a plurality of alternating first and second optical layers having different indices of refraction and a left band edge in a range from 600 nanometers to 900 nanometers. The multilayer optical film reflects at least a portion of light in a range of wavelengths that corresponds with the absorption bandwidth of the photovoltaic cell. | 03-27-2014 |
| Patent application number | Description | Published |
|---|
| 20100197574 | AQUARETIC AND NATRIURETIC POLYPEPTIDES LACKING VASODILATORY ACTIVITY - This document provides aquaretic and natriuretic polypeptides. For example, this document provides polypeptides having aquaretic and/or natriuretic activities. In some cases, a polypeptide provided herein can have aquaretic and natriuretic activities, while lacking the ability to lower blood pressure. This document also provides methods and materials for inducing aquaretic and/or natriuretic activities within a mammal. | 08-05-2010 |
| 20110152194 | CHIMERIC NATRIURETIC POLYPEPTIDES AND METHODS FOR INHIBITING CARDIAC REMODELING - Materials and methods related to chimeric polypeptides containing the amino acid sequence of CNP and the C-terminal sequence of DNP. The polypeptides are natriuretic and diuretic, GFR enhancing, cardiac unloading, renin inhibiting and less hypotensive when compared to BNP. The polypeptides also inhibit cardiac fibroblast proliferation. | 06-23-2011 |
| 20110269684 | NATRIURETIC POLYPEPTIDES FOR REDUCING OR PREVENTING RESTENOSIS - Materials and Methods related to using natriuretic polypeptides to reduce proliferation of smooth muscle cells, and to reduce or prevent restenosis. | 11-03-2011 |
| 20130023478 | AQUARETIC AND NATRIURETIC POLYPEPTIDES LACKING VASODILATORY ACTIVITY - This document provides aquaretic and natriuretic polypeptides. For example, this document provides polypeptides having aquaretic and/or natriuretic activities. In some cases, a polypeptide provided herein can have aquaretic and natriuretic activities, while lacking the ability to lower blood pressure. This document also provides methods and materials for inducing aquaretic and/or natriuretic activities within a mammal. | 01-24-2013 |
| 20130143820 | DIURETIC AND NATRIURETIC POLYPEPTIDES - This document provides diuretic and natriuretic polypeptides. For example, this document provides polypeptides having diuretic and/or natriuretic activities. In some cases, a polypeptide provided herein can have diuretic and natriuretic activities, while lacking the ability to lower blood pressure. This document also provides methods and materials for inducing diuretic and/or natriuretic activities within a mammal. | 06-06-2013 |
| 20130281375 | NATRIURETIC POLYPEPTIDES FOR REDUCING OR PREVENTING RESTENOSIS - Materials and methods related to using natriuretic polypeptides to reduce proliferation of smooth muscle cells, and to reduce or prevent restenosis. | 10-24-2013 |
| 20130296241 | AQUARETIC AND NATRIURETIC POLYPEPTIDES LACKING VASODILATORY ACTIVITY - This document provides aquaretic and natriuretic polypeptides. For example, this document provides polypeptides having aquaretic and/or natriuretic activities. In some cases, a polypeptide provided herein can have aquaretic and natriuretic activities, while lacking the ability to lower blood pressure. This document also provides methods and materials for inducing aquaretic and/or natriuretic activities within a mammal. | 11-07-2013 |
| 20140066367 | SUBCUTANEOUS DELIVERY OF A LONG-ACTING NATRIURETIC PEPTIDE - This document provides methods and material related to natriuretic polypeptides. For example, substantially pure polypeptides having a natriuretic peptide activity, nucleic acids encoding polypeptides having a natriuretic peptide activity, host cells containing such nucleic acids, and methods for inducing a natriuretic or diuretic activity within a mammal are provided. | 03-06-2014 |
| 20140179605 | NATRIURETIC POLYPEPTIDE DELIVERY SYSTEMS - This document provides natriuretic polypeptide delivery systems. For example, methods and materials related to natriuretic polypeptide delivery systems, methods and materials related to the use of such delivery systems to deliver natriuretic polypeptides to a mammal over a pro-longed period of time (e.g., weeks to months), and methods and materials related to treating heart failure conditions are provided. | 06-26-2014 |
| 20140357561 | NATRIURETIC POLYPEPTIDE DELIVERY SYSTEMS - This document provides natriuretic polypeptide delivery systems. For example, methods and materials related to natriuretic polypeptide delivery systems, methods and materials related to the use of such delivery systems to deliver natriuretic polypeptides to a mammal over a pro-longed period of time (e.g., weeks to months), and methods and materials related to treating heart failure conditions are provided. | 12-04-2014 |
| 20150368312 | INSULIN SECRETING POLYPEPTIDES - This document provides methods and materials related to insulin secreting polypeptides. For example, polypeptides having the ability to induce insulin secretion and methods and materials for using use such polypeptides to induce insulin secretion and to treat diabetes are provided. | 12-24-2015 |
| 20150374793 | DIURETIC AND NATRIURETIC POLYPEPTIDES - This document provides diuretic and natriuretic polypeptides. For example, this document provides polypeptides having diuretic and/or natriuretic activities. In some cases, a polypeptide provided herein can have diuretic and natriuretic activities, while lacking the ability to lower blood pressure. This document also provides methods and materials for inducing diuretic and/or natriuretic activities within a mammal. | 12-31-2015 |
| 20150376255 | AQUARETIC AND NATRIURETIC POLYPEPTIDES LACKING VASODILATORY ACTIVITY - This document provides aquaretic and natriuretic polypeptides. For example, this document provides polypeptides having aquaretic and/or natriuretic activities. In some cases, a polypeptide provided herein can have aquaretic and natriuretic activities, while lacking the ability to lower blood pressure. This document also provides methods and materials for inducing aquaretic and/or natriuretic activities within a mammal. | 12-31-2015 |
| Patent application number | Description | Published |
|---|
| 20090156908 | Deriving Patient Activity Information from Sensed Body Electrical Information - Electrodes of a subcutaneous monitoring system receive body electrical signals that indicate both cardiac and non-cardiac muscle activity. In general, non-cardiac muscle activity is often correlated with physical activity, and physical activity is typically a strong indicator of patient health. Exemplary systems and methods that detect non-cardiac muscle activity information in sensed body electrical waveforms may provide a diagnostic tool for monitoring physical activity level over time in patients that have subcutaneous monitoring systems. In an illustrative embodiment, systems and methods for presenting patient activity information in a graphical format over intervals of time include processing ECG waveform information to identify and to accumulate non-cardiac muscular activity information during each of the intervals of time. In various implementations, number, intensity, and/or duration of the events that are identified during a time interval may be accumulated and stored for subsequent recall. | 06-18-2009 |
| 20090326398 | SENSING BIOLOGICAL DATA - A system is provided for obtaining and analyzing biological data of a subject. The system includes a biological data recording device that can sense biological signals of a subject over time and record the sensed biological signals as biological data. The system also includes an event time recording device that is physically separate from, and does not communicate with, the biological data recording device. The event time recording device includes a user actuatable component, and also includes a recording component that records user actuation data, which includes a time stamp indication as to when any instances of user actuation occurred. The system also includes equipment that can periodically receive the recorded biological data from the biological data recording device and the user actuation data from the event time recording device, and can correlate the biological data and the user actuation data to generate correlated biological data. | 12-31-2009 |
| 20120143031 | Deriving Patient Activity Information from Sensed Body Electrical Information - Electrodes of a subcutaneous monitoring system receive body electrical signals that indicate both cardiac and non-cardiac muscle activity. In general, non-cardiac muscle activity is often correlated with physical activity, and physical activity is typically a strong indicator of patient health. Exemplary systems and methods that detect non-cardiac muscle activity information in sensed body electrical waveforms may provide a diagnostic tool for monitoring physical activity level over time in patients that have subcutaneous monitoring systems. In an illustrative embodiment, systems and methods for presenting patient activity information in a graphical format over intervals of time include processing ECG waveform information to identify and to accumulate non-cardiac muscular activity information during each of the intervals of time. In various implementations, number, intensity, and/or duration of the events that are identified during a time interval may be accumulated and stored for subsequent recall. | 06-07-2012 |
| Patent application number | Description | Published |
|---|
| 20090299927 | INTEGRATED METHOD OF ENSURING INSTANT MESSAGING SECURITY ON CONFIDENTIAL SUBJECT MATTER - An instant messaging system for securing chat sessions containing confidential subject matter during instant messaging from external entities, the system comprising: a rules engine module configured to continuously build and update a set of rules used to determine when a chat session between a first chat party and a second chat party during an instant messaging session contains confidential or uniquely classified subject matter by loading at least one default rules or previous session rules and enabling a user to provide user-defined rules until the instant message session is ended; and an instant messaging module configured to secure the contents in the chat session based on pre-defined user settings, the contents in the chat session being secured when the contents in the chat session is determined to contain confidential subject matter derived from the set of rules, the chat session is further secured by limiting the exposure of the contents in the chat session to third parties when the chat session is determined to contain confidential subject matter while enabling the first chat party and the second chat party to view the contents in the chat session. | 12-03-2009 |
| 20100026715 | Image Capture and Buffering in a Virtual World Using Situational Measurement Averages - A technique is disclosed for detecting photo opportunities within a virtual environment. In response to detecting a photo opportunity, images of the virtual environment may be captured from perspectives not limited to the user's viewport. A variety of physiological and virtual world parameters are measured to determine when to capture an image of a user interacting with the virtual environment. To improve the quality of images, these parameters may be individually weighted by factors specified by the user. Captured images may be stored in a temporary buffer space, possibly replacing older images. The user may view the buffer contents and select ideal images to move to a permanent gallery. The user's image selections can in turn be used to further improve the quality of future images. | 02-04-2010 |
| 20100026716 | Image Capture and Buffering in a Virtual World - A technique is disclosed for detecting photo opportunities within a virtual environment. In response to detecting a photo opportunity, images of the virtual environment may be captured from perspectives not limited to the user's viewport. A variety of physiological and virtual world parameters are measured to determine when to capture an image of a user interacting with the virtual environment. To improve the quality of images, these parameters may be individually weighted by factors specified by the user. Captured images may be stored in a temporary buffer space, possibly replacing older images. The user may view the buffer contents and select ideal images to move to a permanent gallery. The user's image selections can in turn be used to further improve the quality of future images. | 02-04-2010 |
| 20100180214 | Predatory Behavior Detection and Alert in Virtual Worlds Based on Spatial and Temporal Criteria - Embodiments of the invention provide techniques for protecting a user from being followed by an avatar within an immersive virtual environment. To detect a following avatar, any avatars within a specified range of the user may be identified. Historical data may then be examined to determine if any of the identified avatars has been in the same recent virtual locations as the user. In order to rule out coincidental movements, the likelihood of both avatars being in the same places at the same time may be evaluated. Further, the following avatar may be tested by transporting the user to another location, and then monitoring to determine whether the following avatar also transports to the same location. Upon confirming that the following avatar is actually following the user, avoidance actions may be performed in order to avoid the following avatar. | 07-15-2010 |
| 20100180215 | Detecting Avatar Following in a Virtual Environment - Embodiments of the invention provide techniques for protecting a user from being followed by an avatar within an immersive virtual environment. To detect a following avatar, any avatars within a specified range of the user may be identified. Historical data may then be examined to determine if any of the identified avatars has been in the same recent virtual locations as the user. In order to rule out coincidental movements, the likelihood of both avatars being in the same places at the same time may be evaluated. Further, the following avatar may be tested by transporting the user to another location, and then monitoring to determine whether the following avatar also transports to the same location. Upon confirming that the following avatar is actually following the user, avoidance actions may be performed in order to avoid the following avatar. | 07-15-2010 |
| 20150127776 | STREAMING STATE DATA FOR CLOUD MANAGEMENT - A cloud manager uses streams to monitor state of the cloud. A cloud state streaming policy specifies state data to stream, along with one or more initial operators for processing the streams. An archive mechanism allows archiving the streamed data when specified data in the streams exceeds one or more defined thresholds. A user interface allows adjusting the streaming of cloud state data to focus on data of interest to a user. The cloud manager thus allows a user to determine state of a cloud via the streamed state data. | 05-07-2015 |
| 20150127810 | STREAMING STATE DATA FOR CLOUD MANAGEMENT - A cloud manager uses streams to monitor state of the cloud. A cloud state streaming policy specifies state data to stream, along with one or more initial operators for processing the streams. An archive mechanism allows archiving the streamed data when specified data in the streams exceeds one or more defined thresholds. A user interface allows adjusting the streaming of cloud state data to focus on data of interest to a user. The cloud manager thus allows a user to determine state of a cloud via the streamed state data. | 05-07-2015 |
| 20150128220 | LOCATION BASED AUTHENTICATION OF USERS TO A VIRTUAL MACHINE IN A COMPUTER SYSTEM - An apparatus and method uses location based authentication of a user accessing a virtual machine (VM) by using the physical location of the virtual machine as a criteria for the authentication. When a user requires a logical partition to run in a known, specified physical location, the user specifies the physical location when the VM is created. The specified physical location is then incorporated into the user authentication process. Users are challenged and must know the physical location in order to be authenticated to the system. When a “disruptive event” in the cloud environment occurs that necessitates moving the VM to another location, the original physical location is stored so the virtualization manager later can automatically relocate the VM back to its original physical location. | 05-07-2015 |
| 20150128221 | LOCATION BASED AUTHENTICATION OF USERS TO A VIRTUAL MACHINE IN A COMPUTER SYSTEM - An apparatus and method uses location based authentication of a user accessing a virtual machine (VM) by using the physical location of the virtual machine as a criteria for the authentication. When a user requires a logical partition to run in a known, specified physical location, the user specifies the physical location when the VM is created. The specified physical location is then incorporated into the user authentication process. Users are challenged and must know the physical location in order to be authenticated to the system. When a “disruptive event” in the cloud environment occurs that necessitates moving the VM to another location, the original physical location is stored so the virtualization manager later can automatically relocate the VM back to its original physical location. | 05-07-2015 |
| 20150331761 | HOST SWAP HYPERVISOR THAT PROVIDES HIGH AVAILABILITY FOR A HOST OF VIRTUAL MACHINES - A host swap hypervisor provides a high availability hypervisor for virtual machines on a physical host computer during a failure of a primary hypervisor on the physical host computer. The host swap hypervisor resides on the physical host computer that runs the primary hypervisor, and monitors failure indicators of the primary hypervisor. When the failure indicators exceed a threshold, the host swap hypervisor is then autonomically swapped to become the primary hypervisor on the physical host computer. The original primary hypervisor may then be re-initialized as the new host swap hypervisor. | 11-19-2015 |
| 20150331763 | HOST SWAP HYPERVISOR THAT PROVIDES HIGH AVAILABILITY FOR A HOST OF VIRTUAL MACHINES - A host swap hypervisor provides a high availability hypervisor for virtual machines on a physical host computer during a failure of a primary hypervisor on the physical host computer. The host swap hypervisor resides on the physical host computer that runs the primary hypervisor, and monitors failure indicators of the primary hypervisor. When the failure indicators exceed a threshold, the host swap hypervisor is then autonomically swapped to become the primary hypervisor on the physical host computer. The original primary hypervisor may then be re-initialized as the new host swap hypervisor. | 11-19-2015 |
| Patent application number | Description | Published |
|---|
| 20100047317 | USING BUCKY PAPER AS A THERAPEUTIC AID IN MEDICAL APPLICATIONS - Methods, systems, and uses of bucky paper are provided in the present invention. These embodiments include covering medical implants with single or multiple layers of bucky paper, treating bucky paper with various therapeutics to be released through the bucky paper to a target site, shaping bucky paper into non-conventional configurations for improved therapeutic deliver, and using bucky paper alone or in conjunction with other materials to treat a target site. | 02-25-2010 |
| 20100179645 | MEDICAL DEVICES HAVING MULTIPLE LAYERS - Described herein are medical devices which are configured for implantation or insertion into a subject, preferably a mammalian subject. The medical devices contain one or more multilayer regions, which contain: (a) one or more (typically a plurality of) charged nanoparticle layers and (b) one or more (typically a plurality of) charged polyelectroyte layers. Such multilayers have a number of desirable attributes, including high strength, non-compliance, and flexibility. Also described herein are methods of making such devices. | 07-15-2010 |
| 20100203181 | EXTRUSION APPARATUS FOR MAKING MULTILAYER ARTICLES - In certain aspects of the invention, an extrusion apparatus for making a multilayer article includes multiple discs, each of which has at least one passageway configured to permit fluid flow therethrough in a flow direction. At least one of the discs includes a cone shaped portion extending substantially parallel to the flow direction. | 08-12-2010 |
| 20100280452 | MEDICAL DEVICES HAVING MULTIPLE LAYERS - Described herein are medical devices which are configured for implantation or insertion into a subject, preferably a mammalian subject. The medical devices contain one or more multilayer regions, which contain: (a) one or more (typically a plurality of) charged nanoparticle layers and (b) one or more (typically a plurality of) charged polyelectroyte layers. Such multilayers have a number of desirable attributes, including high strength, non-compliance, and flexibility. Also described herein are methods of making such devices. | 11-04-2010 |
| 20120046608 | Medical Devices - The invention relates to medical balloons, and methods of modifying said balloons by forming a void pattern in their exterior surfaces and filling the voids with a material, such as a fiber or a nanomaterial (e.g., nanotubes, such as carbon nanotubes) and a matrix material, e.g., a polymer. | 02-23-2012 |
| 20120323301 | Medical Device Balloons with Improved Strength Properties and Processes for Producing the Same - A tubular parison for forming a medical device balloon. The parison is formed of a polymeric material, for instance a thermoplastic elastomer. The parison has an elongation at break which is not more than 80% of the elongation of the bulk polymeric material. The elongation of the parison is controlled by altering extrusion conditions. Balloons prepared from the parisons provide higher wall strength and/or higher inflation durability than balloons prepared from conventional parisons of the same material. | 12-20-2012 |
| 20130122060 | USING BUCKY PAPER AS A THERAPEUTIC AID IN MEDICAL APPLICATIONS - Methods, systems, and uses of bucky paper are provided in the present invention. These embodiments include covering medical implants with single or multiple layers of bucky paper, treating bucky paper with various therapeutics to be released through the bucky paper to a target site, shaping bucky paper into non-conventional configurations for improved therapeutic deliver, and using bucky paper alone or in conjunction with other materials to treat a target site. | 05-16-2013 |
| 20140243875 | MEDICAL BALLOON HAVING IMPROVED STABILITY AND STRENGTH - A medical device, the medical device formed at least in part from a melt blend of at least one polymer comprising hydrolysable groups and a carbodiimide. | 08-28-2014 |
| 20140330202 | MEDICAL DEVICE BALLOONS WITH IMPROVED STRENGTH PROPERTIES AND PROCESSES FOR PRODUCING SAME - A tubular parison for forming a medical device balloon. The parison is formed of a polymeric material, for instance a thermoplastic elastomer. The parison has an elongation at break which is not more than 80% of the elongation of the bulk polymeric material. The elongation of the parison is controlled by altering extrusion conditions. Balloons prepared from the parisons provide higher wall strength and/or higher inflation durability than balloons prepared from conventional parisons of the same material. | 11-06-2014 |
| 20150025533 | RENAL NERVE ABLATION CATHETER HAVING TWIST BALLOON - Medical devices and methods for making and using medical devices are disclosed. An example medical device may include a catheter shaft. An expandable balloon may be coupled to the catheter shaft. The balloon may be capable of shifting between a folded configuration and an expanded configuration. A support structure may be coupled to the balloon. The support structure may be capable of shifting the balloon toward the folded configuration. A plurality of elongate flexible electrode assemblies may be disposed on the balloon. The elongate flexible electrode assemblies may be oriented at an angle relative to a longitudinal axis of the balloon. | 01-22-2015 |
| 20150051696 | MEDICAL GUIDEWIRE - A guidewire system may include a guidewire having a relatively stiff proximal section and a relatively flexible distal section joined by a transition region, and a TAVI device slidably disposed on the guidewire. The guidewire may include an expandable element disposed about the transition region. The expandable element may be configured to expand from a collapsed configuration to an expanded configuration. The guidewire may include an expandable element disposed at the distal end. The distal section may be pre-configured to form more than one distal loop. A method of protecting an apex of a left ventricle during a TAVI procedure may include inserting a guidewire into the left ventricle, positioning a transition region adjacent the apex, expanding an expandable element such that the expandable element spans the apex, advancing a TAVI device distally over the guidewire to an aortic valve, and performing a TAVI procedure at the aortic valve. | 02-19-2015 |
| 20150374958 | HIGH PRESSURE BALLOON - Composite fiber reinforced balloons for medical devices are prepared by applying a web of fibers to the exterior of a preformed underlayer balloon, encasing the web with a matrix material to form an assembly, and inserting the assembly into a preformed outer layer balloon to form the composite balloon. | 12-31-2015 |
| 20160089517 | DUAL-LAYER BALLOON DESIGN AND METHOD OF MAKING THE SAME - An expandable medical balloon, the expandable medical balloon comprising a first balloon wall, the first balloon wall comprising a first balloon layer of polyethylene terephthalate having a first intrinsic viscosity, the first layer is outer to a second layer of polyethylene terephthalate, the second balloon layer of polyethylene terephthalate having a second intrinsic viscosity, the second layer is an inner layer, wherein the intrinsic viscosity of the first balloon layer is higher than the intrinsic viscosity of the second balloon layer by about 0.05 dl/g or more. | 03-31-2016 |
| Patent application number | Description | Published |
|---|
| 20110063950 | VIBRATION GENERATION AND DETECTION IN SHEAR WAVE DISPERSION ULTRASOUND VIBROMETRY WITH LARGE BACKGROUND MOTIONS - A method for measuring a mechanical property of a subject includes using an ultrasonic transducer to apply ultrasonic vibration pulses to a vibration origin in the subject in an on-off time sequence in order to impart a harmonic motion at a prescribed frequency to the subject, and when the vibration pulses are off, preferably using the same transducer to apply ultrasonic detection pulses to a motion detection point and to receive echo signals therefrom in order to sense the harmonic motion on the subject at the motion detection point The ultrasonic detection pulses are interspersed with the vibration pulses and can be applied in a non-uniform manner From the received ultrasonic echo signals, a harmonic signal is detected and a characteristic such as amplitude or phase of the detected harmonic signal is calculated using a Kalman filter or interpolation. | 03-17-2011 |
| 20110263978 | Method for Shear Wave Ultrasound Vibrometry with Interleaved Push and Detection Pulses - A shear wave dispersion ultrasound vibrometry (“SDUV”) method for measuring a mechanical property of a subject is provided. Particularly, a set of ultrasonic vibration tone bursts is applied to a vibration origin in the subject so that harmonic vibratory motion is imparted to a tissue of interest. The set of vibration tone bursts effectively act like a single vibration pulse that imparts vibratory motion at larger amplitudes than achievable with a single pulse. Multiple ultrasonic detection pulses are then applied to two or more locations in the tissue of interest in order to measure shear waves propagating outward from the vibration origin. From these measurements, phase or amplitude information related to the shear wave propagation is determined and used to calculate a shear wave speed. Using the shear wave speed information, mechanical properties of the tissue are calculated. | 10-27-2011 |
| 20110319756 | Method for Ultrasound Vibrometry Using Orthogonal Basis Functions - A method for measuring a mechanical property of a subject includes using an ultrasound transducer to apply ultrasonic vibration pulses to a location in a subject in order to induce shear waves at multiple prescribed orthogonal frequencies in the subject. The ultrasound transducer is directed by an excitation signal that is composed of multiple orthogonal basis functions, each having a given frequency component corresponding to the prescribed orthogonal frequencies. The power level of each orthogonal basis function is independently adjustable. The excitation signal can be sparsely sampled, or portions of the excitation signal can be removed in order to improve tissue vibration and to provide for the interleaving ultrasonic vibration and detection pulses. Ultrasonic detection pulses are applied to at least one motion detection point, from which echo signals are received. From the received echo signals, a motion signal is determined, from which mechanical properties of the subject are calculated. | 12-29-2011 |
| 20120226158 | System and Method for Correcting Errors in Shear Wave Measurements Arising From Ultrasound Beam Geometry - A system and method for measuring mechanical properties of a tissue using an ultrasound system is provided. Ultrasound energy is applied to the tissue using the ultrasound system in order to produce shear waves that propagate in the tissue. Measurement data are then acquired by directing ultrasound detection pulses into the tissue. Information about the intensity field of the ultrasound energy used to produce the shear waves is obtained and used to produce a correction factor. This correction factor is applied to the measurement data to correct the measurement data for errors arising from the geometry of the ultrasound energy used to produce the shear waves. From the corrected measurement data, mechanical properties of the tissue are calculated. | 09-06-2012 |
| 20130237821 | System and Method for Model-Independent Quantification of Tissue Viscoelastic Properties Using Ultrasound - A model-independent method for producing a viscoelastic tissue property metric using ultrasound is provided. A mechanical stress, such as an acoustic force, is applied to a tissue using an ultrasound system and tissue displacement resulting from the applied acoustic force is measured. From the tissue displacement measurements, a complex modulus, such as a relative complex modulus, is extracted. A loss tangent is calculated from the extracted complex modulus. Using the calculated loss tangent, viscoelastic tissue property metrics may be calculated. | 09-12-2013 |
| 20140018679 | GENERATION AND ASSESSMENT OF SHEAR WAVES IN ELASTICITY IMAGING - A method for generation and analysis of shear waves in a subject with an ultrasound system. Multiple short ultrasound push pulses are applied, as a set and optionally more than once, to one or more push origins at the subject to produce first and second shear waves of large amplitudes and desired spatial distributions, which are separated in space and time and which have opposite polarity such that initial movements of the subject tissue, respectively caused by the first and second shear waves, occur in opposite directions. At least one mechanical property of the subject (including that represented by shear wave group velocity, phase velocity, and attenuation of a shear wave) is determined based at least in part on a distance between wavefronts of the first and second shear waves. | 01-16-2014 |
| 20140046173 | ULTRASOUND VIBROMETRY WITH UNFOCUSED ULTRASOUND - Methods for measuring mechanical properties of an object or subject under examination with an ultrasound system and using unfocused ultrasound energy are provided. Shear waves that propagate in the object or subject are produced by applying unfocused ultrasound energy to the object or subject, and measurement data is acquired by applying focused or unfocused ultrasound energy to at least one location in the object or subject at which shear waves are present Mechanical properties are then calculated from the acquired measurement data. | 02-13-2014 |
| 20150216507 | SYSTEM AND METHOD FOR SHEAR WAVE ELASTOGRAPHY BY TRANSMITTING ULTRASOUND WITH SUBGROUPS OF ULTRASOUND TRANDUCER ELEMENTS - Systems and methods for performing shear wave elastography using push and/or detection ultrasound beams that are generated by subsets of the available number of transducer elements in an ultrasound transducer. These techniques provide several advantages over currently available approaches to shear wave elastography, including the ability to use a standard, low frame rate ultrasound imaging system and the ability to measure shear wave speed throughout the entire field-of-view rather than only those regions where the push beams are not generated. | 08-06-2015 |
| 20150265249 | SYSTEM AND METHOD FOR SHEAR WAVE GENERATION WITH STEERED ULTRASOUND PUSH BEAMS - A system and method for performing a steered push beam (SPB) technique to create multiple foci generated by the interference of different ultrasound push beams to create shear waves and, based thereon, generate a report indicating mechanical properties about an object. | 09-24-2015 |
| 20150305719 | SHEAR WAVE ATTENUATION FROM K-SPACE ANALYSIS SYSTEM - The present invention provides a system and method for ultrasound processes using wave attenuation derived from k-space analysis by analyzing spatial frequency domain data. | 10-29-2015 |
| Patent application number | Description | Published |
|---|
| 20080319494 | System and method for preventing recurrence of atrial tachyarrhythmia - A system and method for providing pacing pulses after a cardioversion/defibrillation shock, where the pacing pulses have a pacing rate at an initial value. The pacing rate is decreased from the initial value until at least one intrinsic cardiac contraction is detected. In one embodiment, the pacing rate is decreased by a set amount after pacing a set number of cardiac cycles. Providing the set number of pacing pulses and decreasing the pacing rate by the set amount is then repeated until at least one intrinsic cardiac contraction is detected. An intrinsic cardiac rate is then determined from the at least one intrinsic cardiac contraction. The pacing rate is then increased and maintained to be above (i.e., greater than) the intrinsic cardiac rate. | 12-25-2008 |
| 20100069844 | Devices and Methods for Interstitial Injection of Biologic Agents into Tissue - Apparatus and methods for injecting biological agents into tissue. Devices are provided having elongate shafts and distal injection heads for driving needles into tissue and injecting medical agents into the tissue through the needles. A longitudinal force directed along the shaft can be translated to a needle driving force. Some devices provide controllably variable needle penetration depth. Devices include mechanical needle drivers utilizing four link pantographs, rack and pinions, and drive yokes for driving a first needle bearing body toward a second tissue contacting body. Other devices include inflatable members for driving and retracting needles. Still other devices include magnets for biasing the needles in extended and/or retracted positions. The invention includes minimally invasive methods for epicardially injecting cardiocyte precursor cells into infarct myocardial tissue. | 03-18-2010 |
| 20100204742 | PATIENT CONTROLLED ATRIAL SHOCK THERAPY - An implanted cardiac device detects an atrial arrhythmia and provides periodically updated atrial arrhythmia status as long as the arrhythmia is ongoing. A patient may request an indication of ongoing atrial arrhythmia status from external to the patient using a patient activator. The patient activator may include a magnet for closing a reed switch in the implanted device to provide the request or may provide the request over a telemetry link to the implanted device. The implanted device may provide the requested atrial arrhythmia status and other information in the form of an audible tone produced by the implanted device or as a message telemetered from the implanted device to the patient activator. The patient activator may include a tone detector and display for providing a visual indication of the atrial arrhythmia status indication. The magnet activator may also be employed to request or withhold atrial shock therapy. | 08-12-2010 |
| 20100268293 | DELAY TO THERAPY FOLLOWING PATIENT CONTROLLED ATRIAL SHOCK THERAPY REQUEST - An implantable cardiac device detects a patient therapy request originating from external to the implantable device. A shock therapy delay period is timed in response to the detection of the patient therapy request. Atrial shock therapy is provided to the patient after expiration of the shock therapy delay period (if the presence of an ongoing atrial arrhythmia is detected). The patient therapy request may be provided by a patient activator including a magnet for operating a reed switch in the implanted device to provide the request. A patient activator including an input and receiver/transmitter circuitry may be employed to request the immediate providing of atrial shock therapy, and/or to set the duration the shock therapy delay period. By allowing specific delays to therapy after a therapy request, a patient can prepare for the requested therapy and thereby mitigate therapy discomfort. | 10-21-2010 |
| 20100305639 | METHOD AND APPARATUS FOR USING ATRIAL DISCRIMINATION ALGORITHMS TO DETERMINE OPTIMAL PACING THERAPY AND THERAPY TIMING - A system and method which employs atrial discrimination algorithms to distinguish between different atrial arrhythmias occurring in a patient for selecting an optimal pacing therapy corresponding to the type of arrhythmia identified. In response to the detection of an atrial rate above the atrial tracking rate, discrimination criteria are applied to a detected atrial activity signal to distinguish between different types of supraventricular tachycardia, such as fast atrial flutter and other atrial flutter at a relatively slower rate, which may be occurring in the patient. The pacer is controlled to provide pacing therapy to a heart in a manner corresponding to the type of supraventricular tachycardia identified. The output of an atrial discrimination algorithm may be tracked and the trend thereof used to improve therapy timing. Various embodiments are disclosed herein. | 12-02-2010 |
| Patent application number | Description | Published |
|---|
| 20150043315 | NEAR-FIELD TRANSDUCER WITH ENLARGED REGION, PEG REGION, AND HEAT SINK REGION - A near-field transducer includes an enlarged region having a top side adjacent to a magnetic pole, a base side opposite the top side, and a circumference that extends from proximal to a media-facing surface to distal to a media-facing surface. The near-field transducer includes a peg region in contact with a region of the bas side of the enlarged region, the peg region extending from the enlarged region towards the media-facing surface. The near-field transducer also includes a heat sink region having a contact side, a base side, and a circumference that extends from proximal to the media-facing surface to distal from the media-facing surface. The contact side of the heat sink region is in thermal contact with both the peg region and at least a region of the base side of the enlarged region. | 02-12-2015 |
| 20150235658 | HEAT SINK LAYER ALONG AN APERTURE OF A NEAR-FIELD TRANSDUCER - A recording head includes a near-field transducer proximate a media-facing surface. The near-field transducer includes an aperture surrounded by walls of plasmonic material and a notch protruding within the aperture. The walls are oriented normal to the media-facing surface. A write pole is proximate the near-field transducer. The write pole has a back surface facing away from the media-facing surface and an aperture-facing surface proximate the aperture. A heat sink layer of the plasmonic material is disposed along the back surface and the aperture-facing surface of the write pole. The heat sink layer is thermally and optically coupled to the near-field transducer. | 08-20-2015 |
| 20150279399 | PLANAR PLASMON GENERATOR WITH THICKENED REGION AND PEG REGION - An apparatus (e.g., a heat assisted magnetic recording read/write element) that has an optical component that extends to a location adjacent a media-facing surface of a slider body. The apparatus further includes a planar plasmon antenna that is disposed between the tip portion of the magnetic write pole and the optical component. The planar plasmon antenna can be formed of a plasmonic material operationally capable of a plasmonic excitation in response to an evanescent coupling with an optical mode of the optical component. In some instances, the planar plasmon antenna includes an enlarged region spaced from the optical component and a peg region formed in the enlarged region. The peg region has a thickness in a direction substantially transverse to the optical component that is less than a thickness of a portion of the enlarged region that spaces the peg region from the optical component. | 10-01-2015 |
| 20160133291 | NEAR-FIELD TRANSDUCER WITH RECESSED REGION - A near-field transducer is situated at or proximate an air bearing surface of the apparatus and configured to facilitate heat-assisted magnetic recording on a medium. The near-field transducer includes an enlarged region comprising plasmonic material and having a first end proximate the air bearing surface. The near-field transducer also includes a disk region adjacent the enlarged region and having a first end proximate the air bearing surface. The disk region comprises plasmonic material. A peg region extends from the first end of the disk region and terminates at or proximate the air bearing surface. The near-field transducer further includes a region recessed with respect to the peg region. The recessed region is located between the peg region and the first end of the enlarged region. | 05-12-2016 |
| Patent application number | Description | Published |
|---|
| 20090292326 | GLASS FEEDTHROUGH ASSEMBLIES FOR IMPLANTABLE MEDICAL DEVICES - A feedthrough assembly of an implantable medical device includes a glass insulator containing at least approximately 20 mol % of calcium oxide (CaO), preferably of a CABAL-12 type composition. The assembly is either manufactured so that the glass insulator includes a surface layer including calcium phosphate, preferably of relatively low solubility, or is assembled in the implantable device so that the glass insulator is exposed to phosphate-containing body fluid, when the device is implanted, for the formation of a surface layer including calcium phosphate. | 11-26-2009 |
| 20140277316 | MEDICAL LEADS AND TECHNIQUES FOR MANUFACTURING THE SAME - In some examples, the disclosure relates to a medical device comprising a lead including an electrically conductive lead wire; and an electrode electrically coupled to the lead wire, the electrode including a first portion and a second portion, wherein the first portion defines an exposed outer surface of the electrode and is electrically coupled to the second portion along a first interface, wherein the second portion is electrically coupled to the lead wire along a second interface different from the first interface via welding to couple the lead wire to the electrode, wherein an electrical signal may be transferred between the lead wire and exposed outer surface of the first portion via the second portion, and wherein the first portion is formed from a first material having a first composition, and the second portion is formed from a second material having a second composition different from the first composition. | 09-18-2014 |
| Patent application number | Description | Published |
|---|
| 20100272773 | Use of Drug Polymorphs to Achieve Controlled Drug Delivery From a Coated Medical Device - When making a medical device having a drug coating thereon, the drug having a plurality of characteristic morphological forms, the manufacturing process is controlled to produce a predetermined ratio of said morphological forms on the device. The process has application to drug coated balloons. | 10-28-2010 |
| 20110015664 | Nucleation of Drug Delivery Balloons to Provide Improved Crystal Size and Density - Drug delivery balloons have densely packed crystals of small particle size of the drug thereon. An amorphous drug coating is applied to a balloon surface and annealed to provide the crystals. The balloon surface is nucleated to induce formation of drug crystals in the annealing step to provide the crystals in high density with small size. | 01-20-2011 |
| 20130035483 | METHODS OF CONVERTING AMORPHOUS DRUG SUBSTANCE INTO CRYSTALLINE FORM - A method for converting an amorphous drug, such as everolimus, or other macrolide immunosuppressive drug, into a crystalline form. The method utilizes a slurry of the drug in organic liquid phase and ages the slurry to achieve the conversion. | 02-07-2013 |
| 20130053947 | Medical Device with Crystalline Drug Coating - A medical device having a polymer-free outer surface layer comprising a crystalline drug selected from the group consisting of everolimus, tacrolimus, sirolimus, zotarolimus, biolimus, and rapamycin. The device may be produced by a method comprising the steps of providing a medical device; applying a solution of the drug to said portion of the outer surface to form a coating of amorphous drug; and vapor annealing the drug with a solvent vapor to form crystalline drug; wherein a seed layer of a crystalline form of said drug having a maximum particle size of about 10 μm or less is applied to at least said portion of the outer surface of the device before or after applying the drug solution, but before vapor annealing the amorphous coating. | 02-28-2013 |
| 20150018431 | Lubricious Coating Compositions - In one aspect, the present disclosure pertains to lubricous coating compositions that comprise (a) a higher molecular weight polyvinylpyrrolidone, (b) a lower molecular weight polyvinylpyrrolidone, and (c) a polyfunctional unsaturated crosslinking agent. In some embodiments, such lubricous coating compositions are present in crosslinked form on the surface of a medical article. In some embodiments, the lubricous coating compositions further comprise a solvent, in which case such compositions may be, for example, applied to a substrate in the form of a layer and subsequently crosslinked, thereby forming a lubricious coating on the substrate. In another aspect, the present disclosure is directed to methods for forming various medical articles. | 01-15-2015 |
| 20150182732 | Drug Eluting Balloon With Preferred Drug Orientation To Improve Drug Transfer Efficiency - A catheter comprises a medical balloon having a drug coating. The drug coating comprises drug crystals on a surface of the balloon. The majority of the drug crystals on the surface of the balloon are oriented drug crystals which extend within 5° of a predetermined, non-zero common angle relative to the surface of the balloon from which the crystals extend. | 07-02-2015 |
| 20150238736 | SYSTEMS AND METHODS FOR DELIVERING DRUGS TO A TREATMENT SITE - A catheter system includes a catheter having a first balloon and a second balloon. The first balloon is longitudinally offset from the second balloon along the length of the catheter. The first and second balloons both have expanded and unexpanded states. The second balloon has a drug coating. The catheter system has a first configuration, a second configuration, and a third configuration. In the first configuration, the first balloon is in the unexpanded state and the second balloon is in the unexpanded state. In the second configuration, the first balloon is in the expanded state and the second balloon is in the unexpanded state. In the third configuration, the first balloon is in the expanded state and the second balloon is in the expanded state. | 08-27-2015 |
| 20150250772 | Medical Device with Crystalline Drug Coating - A medical device having a polymer-free outer surface layer comprising a crystalline drug selected from the group consisting of everolimus, tacrolimus, sirolimus, zotarolimus, biolimus, and rapamycin. The device may be produced by a method comprising the steps of providing a medical device; applying a solution of the drug to said portion of the outer surface to form a coating of amorphous drug; and vapor annealing the drug with a solvent vapor to form crystalline drug; wherein a seed layer of a crystalline form of said drug having a maximum particle size of about 10 μm or less is applied to at least said portion of the outer surface of the device before or after applying the drug solution, but before vapor annealing the amorphous coating. | 09-10-2015 |
| 20150351782 | SYSTEMS AND METHODS FOR TREATING ATHEROSCLEROTIC PLAQUE - A system and method for treating atherosclerotic plaque. The system includes a first catheter including an expandable balloon and a second catheter including a lumen in fluid communication with a distal hole. The method includes inserting the first catheter into a body lumen adjacent to a plaque formation, and deploying a balloon from the first catheter adjacent to the plaque formation. In addition, the method includes inserting the second catheter adjacent to the first catheter, and routing the distal end portion of second catheter along at least a portion of the deployed balloon of the first catheter. Further, the method includes routing at least a portion of the second catheter into a subintimal space adjacent to the atherosclerotic plaque. Furthermore, the method includes injecting a therapeutic agent into the subintimal space adjacent to the atherosclerotic plaque. | 12-10-2015 |
| Patent application number | Description | Published |
|---|
| 20140250597 | ADJUSTABLE BED FOUNDATION SYSTEM WITH BUILT-IN SELF-TEST - This disclosure describes built-in self-test techniques for an adjustable bed foundation system. In one example, this disclosure describes a remote controller device for an adjustable bed foundation system, the remote controller device includes a user interface configured to receive input from a user, and a processor configured to initiate, via the user interface, at least one test sequence that tests the remote controller device in response to the received user input, and display, via the user interface, information related to the at least one test sequence. | 09-11-2014 |
| 20140257571 | SWITCHING MEANS FOR AN ADJUSTABLE FOUNDATION SYSTEM - In one example, this disclosure describes an adjustable bed system that includes first and second adjustable foundations, at least one first motor to adjust the first adjustable foundation, at least one second motor to adjust the second adjustable foundation, a configurable device having a first state and a second state, and a central controller in communication with the device, the controller configured to receive an input representing one of the first state and the second state, the controller including a processor configured to control the at least one first motor and the at least one second motor based on the received input. | 09-11-2014 |
| 20140259418 | INFLATABLE AIR MATTRESS WITH LIGHT AND VOICE CONTROLS - In one example, this disclosure describes a method including determining, at a central controller of an air mattress system, whether a user is present on a mattress of the air mattress system, initiating a timer in response to determining that the user is present on the mattress, enabling a light control feature of the air mattress system upon determining that the user is present on the mattress after expiration of the timer, and after enabling the light control feature, transmitting, from the central controller, at least one instruction to turn on at least one light of the air mattress system in response to determining that the user is no longer present on the mattress. | 09-18-2014 |
| 20140259419 | PARTNER SNORE FEATURE FOR ADJUSTABLE BED FOUNDATION - A sleep system comprises at least one mattress including a first sleep area for a first occupant, the first sleep area including a first section for a portion of a body of the first occupant, and a second sleep area adjacent to the first sleep area for a second occupant, the second sleep area including a second section for a portion of a body of the second occupant, an articulation system for articulating the first section and the second section, a first user controller configured to communicate with the articulation system in order to control articulation of the first section, and a second user controller configured to communicate with the articulation system in order to control articulation of the second section, wherein the first user controller is further configured to communicate with the articulation system in order to move the second section into a predetermined position. | 09-18-2014 |
| 20150182033 | INFLATABLE AIR MATTRESS WITH INTEGRATED CONTROL - An air bed system including a plurality of peripheral devices and a pump unit configured to adjust a firmness of an air mattress, the pump unit including a pump. The system further includes a controller configured to execute instructions that cause the pump unit to wirelessly pair with at least one of the plurality of peripheral devices. The pump unit is configured to receive at least one control signal addressed to the at least one of the plurality of peripheral devices, and transmit the at least one control signal to the addressed device. | 07-02-2015 |
| Patent application number | Description | Published |
|---|
| 20090274931 | HARD MAGNET WITH CAP AND SEED LAYERS AND DATA STORAGE DEVICE READ/WRITE HEAD INCORPORATING THE SAME - A method including forming a multilayer structure. The multilayer structure includes a seed layer comprising a first component selected from the group consisting of a Pt-group metal, Fe, Mn, Ir and Co. The multilayer structure also includes an intermediate layer comprising the first component and a second component selected from the group consisting of a Pt-group metal, Fe, Mn, Ir and Co. The second component is different than the first component. The multilayer structure further includes a cap layer comprising the first component. The method further includes heating the multilayer structure to an annealing temperature to cause a phase transformation of the intermediate layer. Also a hard magnet including a seed layer comprising a first component selected from the group consisting of a Pt-group metal, Fe, Mn, Ir and Co. The hard magnet also includes a cap layer comprising the first component. The hard magnet further includes an intermediate layer between the seed layer and the cap layer. The intermediate layer includes the first component and a second component selected from the group consisting of a Pt-group metal, Fe, Mn, Ir and Co. The first component is different than the second component. Additionally, a read/write head including the hard magnet. | 11-05-2009 |
| 20110007426 | TRAPEZOIDAL BACK BIAS AND TRILAYER READER GEOMETRY TO ENHANCE DEVICE PERFORMANCE - A magnetoresistive sensor having a trilayer sensor stack with two ferromagnetic freelayers separated by a nonmagnetic spacer layer is disclosed. The sensor is biased with a back biasing magnet adjacent a back of the trilayer sensor. The back biasing magnet, the trilayer sensor stack, or both have substantially trapezoidal shapes to enhance the biasing field and to minimize noise. In some embodiments, the trilayer sensor or back bias magnet have a shape designed to stabilize a micromagnetic “C” shape or concentrate magnetic flux in the trilayer sensor stack. | 01-13-2011 |
| Patent application number | Description | Published |
|---|
| 20130209835 | MULTIPLE LAYER FEPT STRUCTURE - A method involves depositing a seed layer comprising at least A1 phase FePt. A main layer of A1 phase FePt is deposited over the seed layer. The main layer includes FePt of a different stoichiometry than the seed layer. The seed and main layers are annealed to convert the A1 phase FePt to L10 phase FePt. The annealing involves heating the substrate prior to depositing at least part of the A1 phase FePt of the main or seed layers. | 08-15-2013 |
| 20130244192 | MAGNETIC SENSOR MANUFACTURING - A magnetic sensor comprising a first shield and a second shield and a sensor stack between the first and the second shield, the sensor stack having a plurality of layers wherein at least one layer is annealed using in-situ rapid thermal annealing. In one implementation of the magnetic sensor a seed layer is annealed using in-situ rapid thermal annealing. Alternatively, one of a barrier layer, an AFM layer, and a cap layer is annealed using in-situ rapid thermal annealing. | 09-19-2013 |
| 20140146417 | Data Writer with Tapered Side Shield Sidewalls - A data writer may be generally configured at least with a write pole that has a pole sidewall and a continuous first taper angle connecting leading and trailing edges. The write pole can be positioned adjacent to a side shield that is configured with first and second shield sidewalls tapered to a shield tip that is the closest point between the write pole and side shield. | 05-29-2014 |
| 20140168818 | READ SENSOR FOR RECORDING HEAD - Implementations described and claimed herein provide a read sensor structure having a synthetic anti-ferromagnetic (SAF) structure with a pinning that is canted with respect to an air bearing surface (ABS) of the read sensor. In an implementation of the read sensor, the angle between the pinning direction of a reference layer (RL) and the pinning direction of a free layer (FL) is obtuse. | 06-19-2014 |
| 20160064018 | WRITE HEAD WITH COIL STRUCTURE ALIGNED WITH YOKE - A write head having a main pole having a pole tip proximate an air bearing surface (ABS), the main pole having a leading side and a trailing side. The write head also includes a yoke having a yoke tip recessed from the ABS, and a helical coil wrapped around the main pole and the yoke. The helical coil has a first turn with its front edge at least substantially aligned with the yoke tip. | 03-03-2016 |
